Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis
- 1 March 1996
- journal article
- research article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 84 (3), 405-414
- https://doi.org/10.3171/jns.1996.84.3.0405
Abstract
The authors report findings from a metaanalysis of all published randomized trials of prophylactic nimodipine used in patients who have experienced subarachnoid hemorrhage (SAH). Seven trials were included with a total of 1202 patients suitable for evaluation. Eight outcome measures were examined, including good versus other outcome, good or fair outcome versus other outcome, overall mortality, deficit and/or death attributed to vasospasm, infarction rate as judged by computerized tomography (CT), and deficit and/or death from rebleeding. Nimodipine improved outcome according to all measures examined. The odds of good and of good plus fair outcomes were improved by ratios of 1.86:1 and 1.67:1, respectively, for nimodipine versus control(p<0.005 for both measures). The odds of deficit and/or mortality attributed to vasospasm and CT-assessed infarction rate were reduced by ratios of 0.46:1 to 0.58:1 in the nimodipine group (p<0.008 for all measures). Overall mortality was slightly reduced in the nimodipine group, but the trend was not statistically significant. The rebleeding rate was not increased by nimodipine. A metaregression yielded findings indicating that the treatment effect of nimodipine in individual trials was positively correlated with the severity of SAH in enrolled patients. Although the majority of individual trials examined did not have statistically significant results at the p<0.01 level according to most outcome measures, the metaanalyses confirmed the significant efficacy of prophylactic nimodipine in improving outcome after SAH under the conditions used in these trials.Keywords
This publication has 75 references indexed in Scilit:
- Role of Magnesium in Reducing Mortality in Acute Myocardial InfarctionDrugs, 1993
- Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boardsJAMA, 1992
- Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhageJournal of Neurosurgery, 1989
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- NimodipineDrugs, 1989
- Nimodipine treatment of selected good-risk patients with subarachnoid hemorrhage: No significant difference between present and historical resultsSurgical Neurology, 1988
- Publication Bias: A Problem in Interpreting Medical DataJournal of the Royal Statistical Society Series A: Statistics in Society, 1988
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid HemorrhageNew England Journal of Medicine, 1983
- The file drawer problem and tolerance for null results.Psychological Bulletin, 1979